Medicine and Dentistry
Antidiabetic Activity
100%
Glucagon-Like Peptide-1 Agonist
100%
Adjuvant Therapy
100%
Diabetes
50%
Glucagon Like Peptide 1
50%
Glucagon Like Peptide 1 Receptor
50%
Bariatric Surgery
50%
Receptor
25%
Maturity Onset Diabetes of the Young
25%
Clinical Study
25%
Glucocorticoid
25%
Gut
25%
Combination Therapy
25%
Cell Signaling Pathway
25%
Neuroprotective Agent
25%
Metabolic Regulation
25%
Pharmacology, Toxicology and Pharmaceutical Science
Glucagon Like Peptide 1 Receptor Agonist
100%
Glucagon-Like Peptide-1
50%
Glucagon-Like Peptide 1 Receptor
50%
Clinical Study
25%
Remission
25%
Preclinical Study
25%
Receptor
25%
Combination Therapy
25%
Neuroprotective Agent
25%
Glucocorticoid
25%
Non Insulin Dependent Diabetes Mellitus
25%